Kilpest India has informed that the company has sold 13,19,000 COVID-19 RT-PCR Tests in the month of May, 2021 with an average price of Rs 78 per test. Also Exports against Licenses received worth Rs 8,58,000 was done in May, 2021. The amalgamation application after vetting has been uploaded by BSE on 31/05/21, due to COVID-19 lockdowns some delay occurred, now things should get processed faster, with SEBI approval and thereafter NCLT approval. Company will go for NSE listing, once the amalgamated company is formed after all approvals. The COVID-19 Antigen Test Kit is in advanced stage of development.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: